From past bread notables:
WHAT COUNTRY IS THE GENE STRAIN FROM in the NY patients?
Regarding Candida Auris outbreak in NY that Chuck Schumer wants funding for…..seems to be associated with OTHER COUNTRIES, so IMMIGRATION may be the reason we have it all.
The problem could have been avoided if we did not import foreigners???
According to studies:The phylogenetics of C. auris suggest distinct genotypes exist in different geographical regions with substantial genomic diversity.[12] A variety of sequence-based analytical methods have been used to support this finding. These countries:
The genome isolates originating from other countries as problem being studied other countries, they are finding: Pakistan, India, South Africa, Venezuela, Japan, South Asia (India and Pakistan), South Africa, Venezuela, and Japan , United Kingdom, India, Japan, South Africa, South Korea, and Venezuela, Israel, Asia, South Africa, and Kuwait.
And, it seems the Wikipedia page is being cited in many new articles has been edited often in April prior to the relase of the news.
https://en.wikipedia.org/w/index.php?title=Candida_auris&action=history
Schumer: “We’re here to say, now more than ever, with something as deadly as Candida auris, an ounce of prevention is worth a pound of cure,” Schumer said. “The CDC has the power to declare Candida auris the superbug an emergency and money would flow to New York.”
More than half of the 613 confirmed U.S. cases have been in New York. Illinois has had 156 cases, and New Jersey has had 106.
Here is just a piece from Wikipedia:
History:
C. auris was first described after it was isolated from the ear canal of a 70-year-old Japanese woman at the Tokyo Metropolitan Geriatric Hospital in Japan.[1] It was isolated based on its ability to grow in the presence of the fungicide micafungin, an echinocandin class fungicide.[1] Phenotypic, chemotaxonomic and phylogenetic analyses established C. auris as a new strain of the genus Candida.[1][16]
The first three cases of disease-causing C. auris were reported from South Korea in 2011.[17] Two isolates had been obtained during a 2009 study and a third was discovered in a stored sample from 1996.[17] All three cases had persistent fungemia, i.e. bloodstream infection, and two of the patients subsequently died due to complications.[17] Notably, the isolates initially were misidentified as Candida haemulonii and Rhodotorula glutinis using standard methods, until sequence analysis correctly identified them as C. auris.[17] These first cases emphasize the importance of accurate species identification and timely application of the correct antifungal for the effective treatment of candidiasis with C. auris.[17]
During 2009–2011, 12 C. auris isolates were obtained from patients at two hospitals in Delhi, India.[18] The same genotype was found in distinct settings: intensive care, surgical, medical, oncologic, neonatal, and pediatric wards, which were mutually exclusive with respect to health care personnel.[18] Most had persistent candidemia and a high mortality rate was observed.[18] All isolates were of the same clonal strain, however, and were only identified positively by DNA sequence analysis.[18] As previously, the strain was misidentified with established diagnostic laboratory tests.[18] The Indian researchers wrote in 2013 that C. auris was much more prevalent than published reports indicate since most diagnostic laboratories do not use sequence-based methods for strain identification.[18]
The fungus spread to other continents and eventually, a multi-drug-resistant strain was discovered in Southeast Asian countries in early 2016.[19]
The first report of a C. auris outbreak in Europe was an October 2016 in Royal Brompton Hospital, a London cardio-thoracic hospital.[14] In April 2017, CDC director Anne Schuchat named it a "catastrophic threat".[20] As of May 2017 the CDC had reported 77 cases in the United States on its website. Of these, 69 were from samples collected in New York and New Jersey.[21]
By February 28, 2019, cases of people having contracted C. auris had risen to 587, with 309 reported in New York, 104 in New Jersey and 144 in Illinois, according to the CDC.[3][22]
Since it was first observed in the United Kingdom, it has spread to more than 20 NHS Trust hospitals and infected 200 people.[23]
As of February 2019, the CDC has documented cases of C. auris from the following countries: Australia, Austria, Belgium, Canada, China, Colombia, France, Germany, India, Iran, Israel, Japan, Kenya, Kuwait, Malaysia, the Netherlands, Norway, Oman, Pakistan, Panama, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Switzerland, Taiwan, the United Arab Emirates, the United Kingdom, the United States, and Venezuela.[22]
https://en.wikipedia.org/wiki/Candida_auris